Gardasil
human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed)
Papillomavirus Infections
Uterine Cervical Dysplasia
Condylomata Acuminata
Immunization
Date of authorisation:
Revision: 49
Last updated:
MedicineHumanAuthorised
Cervarix
human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed)
Papillomavirus Infections
Uterine Cervical Dysplasia
Immunization
Date of authorisation:
Revision: 39
Last updated:
MedicineHumanAuthorised
P/13/2010 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Vaccines
PIP number: P/13/2010
Route(s) of administration: Intramuscular use
Pharmaceutical form(s):
Suspension for injection
Suspension for injection in pre-filled syringe
Decision date:
Last updated:
Compliance check: ✔
PIPHuman
Silgard
human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed)
Papillomavirus Infections
Uterine Cervical Dysplasia
Condylomata Acuminata
Immunization
Date of authorisation:
Revision: 33
Last updated:
MedicineHumanWithdrawn
EMEA-000234-PIP02-14 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Vaccines
PIP number: P/0008/2015
Route(s) of administration: Intramuscular use
Pharmaceutical form(s):
Suspension for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Human Papillomavirus1 Type 6 L1 protein / Human Papillomavirus1 Type 11 L1 protein / Human Papillomavirus1 Type 16 L1 protein / Human Papillomavirus1 Type 18 L1 protein - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Vaccines
PIP number: P/111/2009
Route(s) of administration: Intramuscular use
Pharmaceutical form(s):
Suspension for injection
Suspension for injection in pre-filled syringe
Decision date:
Last updated:
Compliance check: ✖
PIPHuman